These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Diagnostic Challenges and Treatment Options for Cutaneous T Cell Pseudolymphoma: A Case Study with Rituximab Treatment. Balode D; Beļajeva L; Ruesseler V; Quaas A; Lejniece S Am J Case Rep; 2020 Jan; 21():e919616. PubMed ID: 31919337 [TBL] [Abstract][Full Text] [Related]
6. CD30-positive Cutaneous Pseudolymphoma Caused by Tocilizumab in a Patient with Rheumatoid Arthritis: Case Report and Literature Review. Inoue A; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M Acta Derm Venereol; 2016 May; 96(4):570-1. PubMed ID: 26631390 [No Abstract] [Full Text] [Related]
7. Cutaneus pseudolymphoma: a case report. Dragonetti E; Cianchini G; Mastrangelo L; Mellone P; Baldi A In Vivo; 2004; 18(5):549-51. PubMed ID: 15523891 [TBL] [Abstract][Full Text] [Related]
8. Papular pseudolymphoma of adults as a variant of acral pseudolymphomatous angiokeratoma of children (APACHE). Wagner G; Rose C; Sachse MM J Dtsch Dermatol Ges; 2014 May; 12(5):423-4. PubMed ID: 24628800 [No Abstract] [Full Text] [Related]
11. [Pseudolymphoma of the skin: ambiguous terminology: a survey among dermatologists and pathologists]. Levy E; Godet J; Cribier B; Lipsker D Ann Dermatol Venereol; 2013 Feb; 140(2):105-11. PubMed ID: 23395491 [TBL] [Abstract][Full Text] [Related]
12. Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma. Singletary HL; Selim MA; Olsen E Arch Dermatol; 2012 May; 148(5):572-4. PubMed ID: 22782150 [No Abstract] [Full Text] [Related]
14. Cutaneous MALT-lymphoma: from cutaneous immunocytoma and pseudolymphoma to the current (and future) conceptions. Fernandez-Flores A Rom J Morphol Embryol; 2013; 54(1):7-12. PubMed ID: 23529303 [TBL] [Abstract][Full Text] [Related]